----

----

**UNITED      STATES**

**SECURITIES      AND EXCHANGE COMMISSION**

**FORM      10-K/A**

**Amendment      No. 1**

**x      ANNUAL      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934**

**December 31, 2006**

**000-52005**

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

| **DELAWARE**                                                                  |   | **11-3504866**                                      |
|-------------------------------------------------------------------------------|--------|-----------------------------------------------------|
| (State                or other jurisdiction of incorporation or organization) |   | (I.R.S.                Employer Identification No.) |

**4940      Broadway Suite 201 San Antonio, TX 78209**

**(210)      824 - 4200**

**None**

**Common      Stock, par value $0.00001 per share**

----

** ̈**

**      Yes  **
**      No**

** ̈**

**      Yes  **
**      No**

**      Yes  **
** ̈**

**      No**

** **

| o  Large                accelerated filer | o  Accelerated                filer | **x**** **Non-accelerated                filer |
|-----------------------------------------------------|-----------------------------------------------|-----------------------------------------------------|

**o      Yes   x      No**

----

**EXPLANATORY      NOTE**

**SIGNATURE**

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

| Date:                June 4, 2007 | **By:                /s/ Dr. Gilbert R. Kaats**                               |
|-----------------------------------|-------------------------------------------------------------------------------|
|                              | Dr.                Gilbert R. Kaats                                           |
|                              | Chairman                of the Board, President & Chief Executive Officer |
|                              | (Principal                Executive and Financial Officer)                    |

----

**Integrative      Health Technologies, Inc.**

*previously      known as Senticore, Inc.*

**AUDITED      FINANCIAL STATEMENTS**

**December      31, 2006**

**TABLE      OF CONTENTS**

|                                                    | **Page**               |
|---------------------------------------------------------|------------------------|
|                                                    |                   |
| INDEPENDENT                AUDITOR’S REPORT       | 5                      |
|                                                    |                   |
| BALANCE                SHEET                            | 6                      |
|                                                    |                   |
| STATEMENTS                OF OPERATIONS                 | 7                      |
|                                                    |                   |
| STATEMENTS                OF CASH FLOWS                 | 8                      |
|                                                    |                   |
| STATEMENTS                OF STOCKHOLDERS’ EQUITY | 9                      |
|                                                    |                   |
| NOTES                TO THE FINANCIAL STATEMENTS        | 10                - 14 |

----

**REPORT      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

----

**INTEGRATIVE      HEALTH TECHNOLOGIES,      INC.**

*previously      known as Senticore, Inc.*

**BALANCE      SHEET**

**As      of December 31, 2006**

| **ASSETS**                                                                                                                                       |   |   |       |
|--------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|------------|
|                                                                                                                                             |   |   |       |
| CURRENT                  ASSETS                                                                                                                  |   |   |       |
| Cash                                                                                                                                             |   | $      | 29,673     |   |
| Controlled                  Affiliated Issuers at value                                                                                          |   |   | 7,980,249  |   |
| Shareholder                  Loan Receivable                                                                                                     |   |   | 34,800     |   |
| Accounts                  Receivable                                                                                                             |   |   | 350,266    |   |
| Inventory                                                                                                                                        |   |   | 94,535     |   |
| TOTAL                  CURRENT ASSETS                                                                                                            |   |   | 8,489,523  |   |
|                                                                                                                                             |   |   |       |   |
| PROPERTY                  AND EQUIPMENT                                                                                                          |   |   |       |   |
| Furniture,                  fixtures, and equipment, Net                                                                                         |   |   | 18,500     |   |
|     Net                  Property and Equipment                                                                              |   |   | 18,500     |   |
|                                                                                                                                             |   |   |       |   |
| OTHER                  ASSETS                                                                                                                    |   |   |       |   |
| Prepaid                  Trials                                                                                                                  |   |   | 1,234,463  |   |
|     Net                  Other Assets                                                                                        |   |   | 1,234,463  |   |
| **TOTAL                  ASSETS**                                                                                                                |   | $      | 9,742,486  |   |
|                                                                                                                                             |   |   |       |   |
| **LIABILITIES                  AND STOCKHOLDERS' EQUITY**                                                                                        |   |   |       |   |
|                                                                                                                                             |   |   |       |   |
| LIABILITIES                                                                                                                                      |   |   |       |   |
| Current                  Liabilities:                                                                                                            |   |   |       |   |
| Accounts                  Payable                                                                                                                |   | $      | 433,392    |   |
| Shareholder                  Loan Payable                                                                                                        |   |   | 187,340    |   |
| **TOTAL                  LIABILITIES**                                                                                                           |   |   | 620,732    |   |
|                                                                                                                                             |   |   |       |   |
| **STOCKHOLDERS'                  EQUITY**                                                                                                        |   |   |       |   |
| Preferred                  Stock ($.01 par value, 20,000,000 shares authorized:  20,000,000                  shares issued and outstanding) |   |   | 200,000    |   |
| Common                  Stock ($.001 par value, 200,000,000 shares authorized: 144,735,787                  shares issued and outstanding)  |   |   | 144,736    |   |
| Additional                  Paid-in-Capital                                                                                                      |   |   | 11,278,056 |   |
| Retained                  Deficit                                                                                                                |   |   | (2,501,038 | ) |
| **TOTAL                  STOCKHOLDERS' EQUITY**                                                                                                  |   |   | 9,121,754  |   |
|                                                                                                                                             |   |   |       |   |
| **TOTAL                  LIABILITIES AND STOCKHOLDERS' EQUITY**                                                                                  |   | $      | 9,742,486  |   |

**The      accompanying notes are an integral part of these audited financial      statements.**

----

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

*previously      known as Senticore, Inc.*

**STATEMENTS      OF OPERATIONS**

**For      the Years Ended December 31, 2006 and 2005**

|                                                                                                               |   |     |        |   |     |   |        | **Cumulative**                     |   |
|--------------------------------------------------------------------------------------------------------------------|--------|----------|-------------|--------|----------|--------|-------------|------------------------------------|--------|
|                                                                                                               |   |     |        |   |     |   |        | **Total                Since**     |   |
|                                                                                                               |   |     |        |   |     |   |        | **Inception**                      |   |
|                                                                                                               |   | **2006** |        |   | **2005** |   |        | **January                5, 1999** |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |
| **SALES                AND COST OF SALES**                                                                         |   |     |        |   |     |   |        |                               |   |
| Sales                                                                                                              |   | $        | 369,672     |   |     | $      | --          |                               |   | $ | 374,947 |   |
| Cost                of Sales                                                                                       |   |     | 164,205     |   |     |   | --          |                               |   |   | 164,205 |   |
| Gross                Profit                                                                                        |   |     | 205,467     |   |     |   | --          |                               |   |   | 210,742 |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| **OPERATING                EXPENSES**                                                                              |   |     |        |   |     |   |        |                               |   |   |   |   |
| Stock                based compensation                                                                            |   |     | --          |   |     |   | --          |                               |   |   | 2,586,341 |   |
| Stock                based interest                                                                                |   |     | --          |   |     |   | --          |                               |   |   | 471,420 |   |
| Selling,                general and administrative                                                                 |   |     | 45,569      |   |     |   | 55,172      |                               |   |   | 1,361,174 |   |
| Total                Operating Expenses                                                                            |   |     | 45,569      |   |     |   | 55,172      |                               |   |   | 4,418,935 |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| **OTHER                INCOME (LOSS)**                                                                             |   |     |        |   |     |   |        |                               |   |   |   |   |
| Loss                from disposal of fixed assets                                                                  |   |     | --          |   |     |   | --          |                               |   |   | (6,000 | ) |
| Loss                on equity of LLC                                                                               |   |     | --          |   |     |   | --          |                               |   |   | (109,000 | ) |
| Gain                on Sale of Investments                                                                         |   |     | 234,769     |   |     |   | --          |                               |   |   | 234,769 |   |
| Total                Other Income (Loss)                                                                           |   |     | 234,769     |   |     |   | --          |                               |   |   | 119,769 |   |
| Net                Income (Loss) From Operations before tax expense                                                |   |     | 394,667     |   |     |   | (55,172     | )                                  |   |   | (4,088,424 | ) |
| Income                Tax Expense                                                                                  |   |     | --          |   |     |   | --          |                               |   |   | -- |   |
| Net                Income (Loss) From Operations                                                                   |   |     | 394,667     |   |     |   | (55,172     | )                                  |   |   | (4,088,424 | ) |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| **OTHER                COMPREHENSIVE INCOME**                                                                      |   |     |        |   |     |   |        |                               |   |   |   |   |
| Unrealized                Gain (Loss) on Mark-to-market investment portfolio, net                of  tax |   |     | 536,512     |   |     |   | --          |                               |   |   | 531,512 |   |
| Total                Other Comprehensive Income                                                                    |   |     | 536,512     |   |     |   | --          |                               |   |   | 531,512 |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| Comprehensive                Income                                                                                |   | $        | 931,179     |   |     | $      | (55,172     | )                                  |   | $ | (3,556,912 | ) |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| Net                Loss Per Common Share -- Basic & Fully Diluted                                              |   | $        | 0.01        |   |     |   | *           |                               |   |   |   |   |
|                                                                                                               |   |     |        |   |     |   |        |                               |   |   |   |   |
| Weighted                Average Common Shares Outstanding                                                          |   |     | 144,735,787 |   |     |   | 181,145,154 |                               |   |   |   |   |

**The      accompanying notes are an integral part of these audited financial      statements.**

----

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

*previously      known as Senticore, Inc.*

**STATEMENTS      OF CASH FLOWS**

**For      the Years Ended December 31, 2006 and 2005**

|                                                                                                                     |   |     |       |   |     |   |       | **Cumulative**                     |   |
|--------------------------------------------------------------------------------------------------------------------------|--------|----------|------------|--------|----------|--------|------------|------------------------------------|--------|
|                                                                                                                     |   |     |       |   |     |   |       | **Total                Since**     |   |
|                                                                                                                     |   |     |       |   |     |   |       | **Inception**                      |   |
|                                                                                                                     |   | **2006** |       |   | **2005** |   |       | **January                5, 1999** |   |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |
| **CASH                FLOWS FROM OPERATING ACTIVITIES**                                                                  |   |     |       |   |     |   |       |                               |   |
| Net                Comprehensive Income (loss)                                                                           |   | $        | 931,179    |   |     | $      | (55,172    | )                                  |   | $ | (3,086,492 | ) |
| Adjustments                to reconcile net increase (decrease):                                                         |   |     |       |   |     |   |       |                               |   |   |   |   |
| Depreciation                                                                                                             |   |     | --         |   |     |   | --         |                               |   |   | 24,318 |   |
| Loss                on Disposal of fixed assets                                                                          |   |     | --         |   |     |   | --         |                               |   |   | 6,000 |   |
| Loss                on Equity in LLC                                                                                     |   |     | --         |   |     |   | --         |                               |   |   | 109,000 |   |
| Stock                based interest                                                                                      |   |     | --         |   |     |   | 23,750     |                               |   |   | 495,170 |   |
| Stock                based compensation                                                                                  |   |     | --         |   |     |   | --         |                               |   |   | 2,600,341 |   |
| Other                stock based expenses                                                                                |   |     | --         |   |     |   | --         |                               |   |   | 914,174 |   |
| Proceeds                from sale of investments                                                                         |   |     | 260,897    |   |     |   | --         |                               |   |   | 260,897 |   |
| Realized                Gain on sale of investments                                                                      |   |     | (234,769   | )      |     |   | --         |                               |   |   | (234,769 | ) |
| Unrealized                Gain on Mark to Market Investment Portfolio                                                    |   |     | (536,512   | )      |     |   | --         |                               |   |   | (531,512 | ) |
| (Increase)                decrease in other assets                                                                       |   |     | (34,800    | )      |     |   | 7,867      |                               |   |   | (34,800 | ) |
| (Increase)                in available for sale investments                                                              |   |     | --         |   |     |   | (1,338,732 | )                                  |   |   | (1,338,732 | ) |
| Increase                (decrease) in accounts payable and accrued payables                                              |   |     | 92,216     |   |     |   | 62,107     |                               |   |   | 177,831 |   |
| **NET                CASH PROVIDED (USED) IN OPERATING ACTIVITIES**                                                      |   |     | 478,211    |   |     |   | (1,300,180 | )                                  |   |   | (638,574 | ) |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |   |   |   |
| **CASH                FLOWS FROM INVESTING ACTIVITIES**                                                                  |   |     |       |   |     |   |       |                               |   |   |   |   |
| Investment                in Portfolio Company                                                                           |   |     | (6,256     | )      |     |   | --         |                               |   |   | (6,256 | ) |
| Net                Proceeds from sale of assets                                                                          |   |     | 4,500      |   |     |   | --         |                               |   |   | 4,500 |   |
| Purchases                of property, plant, and equipment                                                               |   |     | --         |   |     |   | --         |                               |   |   | (5,789 | ) |
| Goodwill                acquired (given back to seller due to unwinding)                                                 |   |     | --         |   |     |   | 908,759    |                               |   |   | -- |   |
| Software                received (given back due to unwinding) in purchase of                Pokerbook                   |   |     | --         |   |     |   | 111,471    |                               |   |   | (18,529 | ) |
| **NET                CASH FROM INVESTING ACTIVITIES**                                                                    |   |     | (1,756     | )      |     |   | 1,020,230  |                               |   |   | (26,074 | ) |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |   |   |   |
| **CASH                FLOWS FROM FINANCING ACTIVITIES**                                                                  |   |     |       |   |     |   |       |                               |   |   |   |   |
| Proceeds                from borrowings under note payable                                                               |   |     | --         |   |     |   | --         |                               |   |   | 669,600 |   |
| Repayments                under note payable                                                                             |   |     | (448,034   | )      |     |   | (369,600   | )                                  |   |   | (785,358 | ) |
| Excess                of outstanding checks over bank balance                                                            |   |     | --         |   |     |   | 3,302      |                               |   |   | 3,302 |   |
| Proceeds                from sale of land                                                                                |   |     | --         |   |     |   | --         |                               |   |   | 135,000 |   |
| Incurrence                (repayment) of advances                                                                        |   |     | --         |   |     |   | 189,000    |                               |   |   | -- |   |
| Advances                from stockholders                                                                                |   |     | --         |   |     |   | --         |                               |   |   | 112,413 |   |
| Capital                contributions                                                                                     |   |     | --         |   |     |   | --         |                               |   |   | 19,846 |   |
| Proceeds                from issuance of common stock                                                                    |   |     | --         |   |     |   | 458,500    |                               |   |   | 539,518 |   |
| **NET                CASH (USED) IN FINANCING ACTIVITIES**                                                               |   |     | (448,034   | )      |     |   | 281,202    |                               |   |   | 694,321 |   |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |   |   |   |
| **NON-CASH                FLOW INVESTING ACTIVITIES**                                                                    |   |     |       |   |     |   |       |                               |   |   |   |   |
|  Issuance                of preferred stock (acquisition of companies)                                              |   |     | 7,469,025  |   |     |   | --         |                               |   |   | 7,469,025 |   |
|  Acquisitions                of wholly owned subsidiaries, fixed assets, intangibles and                liabilities |   |     | (7,469,025 | )      |     |   | --         |                               |   |   | (7,469,025 | ) |
|  Issuance                of portfolio holding in exchange for debt reduction                                        |   |     | 677,373    |   |     |   | --         |                               |   |   | 677,373 |   |
|  Debt                reduction in exchange for portfolio holding                                                    |   |     | (677,373   | )      |     |   | --         |                               |   |   | (677,373 | ) |
| **NET                NON-CASH INVESTING ACTIVITIES**                                                                     |   |     | --         |   |     |   | --         |                               |   |   | -- |   |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |   |   |   |
| **INCREASE                (DECREASE) IN CASH**                                                                           |   |     | 28,421     |   |     |   | 1,252      |                               |   |   | 29,673 |   |
|                                                                                                                     |   |     |       |   |     |   |       |                               |   |   |   |   |
| **CASH                AND CASH EQUIVALENTS**                                                                             |   |     |       |   |     |   |       |                               |   |   |   |   |
| **Beginning                of Period**                                                                                   |   |     | 1,252      |   |     |   | --         |                               |   |   | -- |   |
| **Ending                of Period**                                                                                      |   | $        | 29,673     |   |     | $      | 1,252      |                               |   | $ | 29,673 |   |

**The      accompanying notes are an integral part of these audited financial      statements.**

----

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

*previously      known as Senticore, Inc.*

**STATEMENTS      OF STOCKHOLDERS' EQUITY**

**For      the Years Ended December 31, 2006 and 2005**

|                                                                 | **Common**  |    | **Common** |   | **Preferred** |        | **Preferred** |   | **Deferred                Stock** |   | **Additional**   |   |         |     |
|----------------------------------------------------------------------|-------------|---------|------------|--------|---------------|-------------|---------------|--------|-----------------------------------|--------|------------------|--------|--------------|----------|
|                                                                 | **Shares**  |    | **Stock**  |   | **Shares**    |        | **Shares**    |   | **and                Interest**   |   | **Paid-in**      |   | **Retained** |     |
|                                                                 | **(000's)** |    | **$**      |        |          | **(000's)** |          | **$**  |                                   |   | **Compensation** |   | **Capital**  |     | **Deficit** |   |
|                                                                 |        |    |       |   |          |        |          |   |                              |   |             |   |         |     |   |   |
| Balances,                December 31, 2003                           |        | 40,040  |       | $      | 40,040        |        |          | --     |                              | $      | --               |   | $            | (314,950 | ) | $ | 492,256 |   | $ | (881,670 | ) |
| Shares                canceled                                       |        | (12,000 |       |   | (12,000       | )           |          | --     |                              |   | --               |   |         | --       |   |   | -- |   |   | -- |   |
| Amortization                of deferred compensation                 |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | 291,200  |   |   | -- |   |   | -- |   |
| Issuance                of stock for services                        |        | 21,841  |       |   | 21,841        |        |          | --     |                              |   | --               |   |         | --       |   |   | 2,107,417 |   |   | -- |   |
| Issuance                of stock for interest, payable, acquisitions |        | 74,150  |       |   | 74,150        |        |          | --     |                              |   | --               |   |         | --       |   |   | 971,603 |   |   | -- |   |
| Net                Income (Loss) for the year                        |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | --       |   |   | -- |   |   | (2,835,517 | ) |
| Balances,                December 31, 2004                           |        | 124,031 |       | $      | 124,031       |        |          | --     |                              | $      | --               |   | $            | (23,750  | ) | $ | 3,571,276 |   | $ | (3,717,187 | ) |
| Issuance                of stock for cash                            |        | 34,727  |       |   | 34,727        |        |          | --     |                              |   | --               |   |         | --       |   |   | 401,386 |   |   | -- |   |
| Issuance                of stock for services                        |        | 22,387  |       |   | 22,387        |        |          | --     |                              |   | --               |   |         | --       |   |   | -- |   |   | -- |   |
| Amortization                of deferred compensation                 |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | 23,750   |   |   | -- |   |   | -- |   |
| Net                Income (Loss) for the year                        |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | --       |   |   | -- |   |   | (55,172 | ) |
| Balances,                December 31, 2005                           |        | 181,145 |       | $      | 181,145       |        |          | --     |                              | $      | --               |   | $            | --       |   | $ | 3,972,662 |   | $ | (3,772,359 | ) |
| Correction                of an error                                |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | --       |   |   | 20 |   |   | -- |   |
| Shares                canceled                                       |        | (36,409 |       |   | (36,409       | )           |          | --     |                              |   | --               |   |         | --       |   |   | 36,349 |   |   | -- |   |
| Issuance                of stock for acquisitions                    |        | --      |       |   | --            |        |          | 20,000 |                              |   | 200,000          |   |         | --       |   |   | 7,269,025 |   |   | -- |   |
| Net                Income (Loss) for the year                        |        | --      |       |   | --            |        |          | --     |                              |   | --               |   |         | --       |   |   | -- |   |   | 1,271,321 |   |
| Balances,                December 31, 2006                           |        | 144,736 |       | $      | 144,736       |        |          | 20,000 |                              | $      | 200,000          |   | $            | --       |   | $ | 11,278,056 |   | $ | (2,501,038 | ) |

**The      accompanying notes are an integral part of these audited financial      statements**

----

**INTEGRATIVE      HEALTH TECHNOLOGIES, INC.**

**NOTE      A—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

**Business      Activity**

**Business      Description**

**Basis      of Presentation**

**Cash      and Cash Equivalents**

**Management’s      Use of Estimates**

**Revenue      Recognition**

----

**Comprehensive      Income (Loss)**

*“Reporting Comprehensive Income”*

**Development      Stage**

**Net      Income per Common Share**

**Deferred      Taxes**

*“Accounting for Income Taxes.”*

**Impairment      of Long-Lived Assets**

*Accounting for the Impairment or Disposal of Long-Lived Assets” (“SFAS      144’).*

**Fair      Value of Financial Instruments**

**Accounts      Receivable**

**Stock-Based      Compensation**

----

**Recent      Accounting Pronouncements**

**NOTE      B—SUPPLEMENTAL CASH FLOW INFORMATION**

|                        |   | **December                31, 2006** |   |
|-----------------------------|--------|--------------------------------------|--------|
|                        |   |                                 |   |
| Income                Taxes |   | $                                    | --     |   |
| Interest                    |   | $                                    | --     |   |

**NOTE      C—SEGMENT REPORTING**

*“Disclosures about Segments of an Enterprise      and Related Information.”*

**NOTE      D—COMMITMENTS**

----

**NOTE      E—INCOME TAXES**

| Total                deferred tax assets                            |   | $      | 124,000  |   |
|---------------------------------------------------------------------|--------|--------|----------|--------|
| Valuation                allowance                                  |   |   | (124,000 | )      |
|      Net                deferred tax asset |   | $      | --       |   |

| Income                tax computed at the federal statutory rate      |   |   | 34.0  | %  |
|-----------------------------------------------------------------------|--------|--------|-------|----|
| State                income taxes, net of federal tax benefit         |   |   | 4.8   | %  |
| Valuation                allowance                                    |   |   | (38.8 | %) |
|      Total                deferred tax asset |   |   | 0     | %  |

**NOTE      F—NOTES PAYABLE AND SHAREHOLDER RECEIVABLE/RELATED      PARTY**

**NOTE      G—RELATED PARTY TRANSACTIONS**

**NOTE      H—SUBSEQUENT EVENTS**

----

**NOTE      I—CONTROLLED AFFILIATED ISSUERS**

| **Publicly-Traded                Companies FMV at 12/31/2006**    | **Acquisition                Date** |   | **Shares** |       |   | **Price                per share** |       |   | **Fair                Market Value** |   |      | **Cost**  |   |   | **Unrealized                Gain(Loss)** |      |
|-------------------------------------------------------------------|-------------------------------------|--------|------------|------------|--------|------------------------------------|------------|--------|--------------------------------------|--------|-----------|-----------|--------|--------|------------------------------------------|-----------|
| Taj                Systems (TJSS)                                 |                                |   |       | 1,281,886  |   |                               | $          | 0.115  |                                 |   | $         | 147,417   |   |   | $                                        | 236,233   |   |   | $ | (88,816 | ) |
| AdZone                Research (ADZR)                             |                                |   |       | 882,353    |   |                               | $          | 0.003  |                                 |   | $         | 2,647     |   |   | $                                        | --        |   |   | $ | 2,647 |   |
| Beere                Financial (BRFG)                             |                                |   |       | 2,308      |   |                               | $          | 0.100  |                                 |   | $         | 231       |   |   | $                                        | 10,000    |   |   | $ | (9,769 | ) |
| Integrated                Health Tech (IHT)                       |                                |   |       | 6,874      |   |                               | $          | 0.560  |                                 |   | $         | 3,849     |   |   | $                                        | 6,256     |   |   | $ | (2,407 | ) |
|                                                              |                                |   | *subtotal* |       |   |                               |       |   |                                 | $      | 154,144   |      |   | $      | 252,489                                  |      |   |   |   |   |
| **Non                Controlled Companies (Non-Publicly traded)** |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   |   |   |   |
| 8%                Equity Position in AlgaeCal International       | October                2006         |   |       |       |   |                               |       |   |                                 |   | $         | 320,000   |   |   | $                                        | 320,000   |   |   | $ | -- |   |
| The                Justice Fund, a privately held corporation     |                                |   |       | 11,000,000 |   |                               | $          | 0.100  |                                 |   | $         | 110,000   |   |   | $                                        | --        |   |   | $ | 110,000 |   |
|                                                              |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   |   |   |   |
| **Controlled                Companies (Non-Publicly traded)**     |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   |   |   |   |
| 100%                Health and Medical Research, Inc.             | August                2006          |   |       |       |   |                               |       |   |                                 |   | $         | 7,361,998 |   |   | $                                        | 6,531,106 |   |   | $ | 830,892 |   |
| 100%                HealthTech Products, LLC                      | August                2006          |   |       |       |   |                               |       |   |                                 |   | $         | --        |   |   | $                                        | --        |   |   | $ | -- |   |
| 100%                HealthTech Development, LLC                   | August                2006          |   |       |       |   |                               |       |   |                                 |   | $         | 34,107    |   |   | $                                        | --        |   |   | $ | 34,107 |   |
|                                                              |                                |   | *subtotal* |       |   |                               |       |   |                                 | $      | 7,826,105 |      |   | $      | 6,851,106                                |      |   |   |   |   |
|                                                              |                                |   |       |       |   |                               | **Totals** |   |                                 | $      | 7,980,249 |      |   | $      | 7,103,595                                |      |   |   |   |   |
|                                                              |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   |   |   |   |
| **Unrealized                Gain (Loss) at 12/31/2006**           |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   | $ | 876,653 |   |
|                                                              |                                |   |       |       |   |                               |       |   |                                 |   |      |      |   |   |                                     |      |   |   |   |   |   |
| **Portfolio                Holdings @ at 12/31/2006**             |                                |   |       |       |   |                               |       |   |                                 |   | $         | 7,980,249 |   |   |                                     |      |   |   |   |   |   |

----